LOS ANGELES CAPITAL MANAGEMENT LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$211,000
-51.2%
21,380
-46.3%
0.00%
-50.0%
Q4 2020$432,000
+1.6%
39,832
-3.5%
0.00%0.0%
Q3 2020$425,000
-60.6%
41,272
-20.2%
0.00%
-60.0%
Q2 2020$1,080,000
+361.5%
51,722
+116.3%
0.01%
+400.0%
Q1 2020$234,00023,9170.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders